Your browser doesn't support javascript.
loading
USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism.
Gan, Jin; Pinto-Fernández, Adán; Flierman, Dennis; Akkermans, Jimmy J L L; O'Brien, Darragh P; Greenwood, Helene; Scott, Hannah Claire; Fritz, Günter; Knobeloch, Klaus-Peter; Neefjes, Jacques; van Dam, Hans; Ovaa, Huib; Ploegh, Hidde L; Kessler, Benedikt M; Geurink, Paul P; Sapmaz, Aysegul.
Afiliación
  • Gan J; Department of Cell and Chemical Biology, Division of Chemical Biology and Drug Discovery, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.
  • Pinto-Fernández A; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Flierman D; Chinese Academy for Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
  • Akkermans JJLL; Target Discovery Institute, Nuffield Department of Medicine, Centre for Medicines Discovery, University of Oxford, Oxford OX3 7FZ, United Kingdom.
  • O'Brien DP; Department of Cell and Chemical Biology, Division of Chemical Biology and Drug Discovery, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.
  • Greenwood H; Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center LUMC, Leiden 2333 ZC, The Netherlands.
  • Scott HC; Target Discovery Institute, Nuffield Department of Medicine, Centre for Medicines Discovery, University of Oxford, Oxford OX3 7FZ, United Kingdom.
  • Fritz G; Target Discovery Institute, Nuffield Department of Medicine, Centre for Medicines Discovery, University of Oxford, Oxford OX3 7FZ, United Kingdom.
  • Knobeloch KP; Chinese Academy for Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
  • Neefjes J; Department of Cellular Microbiology, University of Hohenheim, Stuttgart 70599, Germany.
  • van Dam H; Institute of Neuropathology, Faculty of Medicine, Department of Molecular Genetics, University of Freiburg, Freiburg 79106, Germany.
  • Ovaa H; Centre for Integrative Biological Signalling Studies, Department of Molecular Genetics, University of Freiburg, Freiburg 79104, Germany.
  • Ploegh HL; Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center LUMC, Leiden 2333 ZC, The Netherlands.
  • Kessler BM; Department of Cell and Chemical Biology, Division of Chemical Biology and Drug Discovery, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.
  • Geurink PP; Department of Cell and Chemical Biology, Division of Chemical Biology and Drug Discovery, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.
  • Sapmaz A; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A ; 120(50): e2315163120, 2023 Dec 12.
Article en En | MEDLINE | ID: mdl-38055744
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Citocinas Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Citocinas Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos